|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02500 VENUS MEDTECH-B
Nominal 
1.225 +0.055 (+4.701%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 135,498 | -27.594% | 306,786 | 470,833 | 491,373 | 406,461 |
| Cost of Sales | (41,977) | -14.592% | (94,954) | (103,087) | (102,168) | (92,463) |
| Gross Profit | 93,521 | -32.225% | 211,832 | 367,746 | 389,205 | 313,998 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (5,014) | -- | 1,707 | (21,441) | 2,210 | (21,972) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (2,607) | 15.099% | (2,104) | (4,154) | (12,381) | (13,943) | |
| Profit / (Loss) before Taxation | (194,644) | 40.472% | (404,886) | (740,713) | (735,340) | (1,156,344) | |
| Taxation | 3,336 | -12.025% | (2,807) | 23,340 | 6,284 | 34,302 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 3,066 | 25,302 | 64,343 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (191,308) | 41.949% | (407,693) | (714,307) | (703,754) | (1,057,699) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 9,027 | 25.864% | 12,981 | 6,297 | 28,259 | 9,975 |
| Depreciation & Amortisation | 44,658 | -9.541% | 97,327 | 111,109 | 124,787 | 112,352 |
| Directors' Emoluments | -- | -- | -- | 7,376 | 3,905 | 4,539 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -44.000 | 41.935% | -93.000 | -163.000 | -161.000 | -242.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.734) | 0.054 | (1.393) | (1.666) |
| NBV per share ($) | 3.460 | -- | 3.997 | 5.014 | 6.623 | 8.181 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -191,308 |
| %Change | 41.949% |
| EPS / (LPS) | RMB -0.440 |
| NBV Per Share (¥) | RMB 3.460 |